Physician profile
Mark A Versnick
NPI 1811146533
$15,397.52
in general payments reported to CMS, 2019-2025
33 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,497 · 2020: $1,062 · 2021: $6,648 · 2022: $1,427 · 2023: $919 · 2024: $493 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,811.77 | 2019-2025 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $1,969.00 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Epsfl, LLC | $288.24 | 2023 | |
| Organogenesis INC. | $203.84 | 2019-2025 | Puraply, Puraply Am, Apligraf |
| Imbed Biosciences INC. | $96.58 | 2023 | |
| Davol INC. | $86.73 | 2021-2025 | Phasix Mesh, Arista Ah Flexitip |
| Boston Scientific Corporation | $81.35 | 2023 | Axios |
| Merck Sharp & Dohme LLC | $79.02 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Ethicon US, LLC | $76.26 | 2019-2022 | |
| Convatec INC. | $74.41 | 2024 | |
| Hologic Sales and Service, LLC | $64.37 | 2023-2025 | Coolseal Generator, Biozorb, Localizer |
| Baxter Healthcare | $63.58 | 2023 | Renal - Extraneal Solution |
| Kci USA, INC. | $47.50 | 2019-2021 | |
| Kerecis Limited | $43.39 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Innocoll Pharmaceuticals Limited | $43.11 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $38.62 | 2022-2023 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $38.12 | 2021 | |
| Abbvie INC. | $36.95 | 2021 | |
| Integra Lifesciences Corporation | $35.68 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Corcept Therapeutics | $27.80 | 2024 | Korlym |
| Hologic INC | $22.15 | 2022 | |
| Novo Nordisk INC | $18.75 | 2020 | |
| Abbott Laboratories | $18.46 | 2019 | |
| Aroa Biosurgery Incorporated | $16.40 | 2025 | |
| Melinta Therapeutics, LLC | $16.34 | 2023 | Orbactiv, Kimyrsa |
| Braintree Laboratories, INC. | $15.40 | 2023 | Sutab |
| Bard Peripheral Vascular, INC. | $14.90 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.86 | 2023 | Nuzyra |
| Medela LLC | $12.75 | 2022 | |
| Reprise Biomedical, INC. | $12.49 | 2025 | Miro3d |
| Acell, INC. | $12.04 | 2019 | |
| Lemaitre Vascular, INC. | $11.85 | 2019 | |
| Next Science LLC | $4.81 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Versnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.